CHAPTER 1. METHODOLOGY AND SCOPE
1.1. MARKET SEGMENTATION AND SCOPE
1.1.1. REGIONAL SCOPE
1.1.2. ESTIMATES AND FORECAST TIMELINE
1.2. MARKET DEFINITIONS
1.3. RESEARCH METHODOLOGY
1.4. INFORMATION PROCUREMENT
1.4.1. PURCHASED DATABASE:
1.4.2. GVR’S INTERNAL DATABASE
1.4.3. SECONDARY SOURCES
1.4.4. PRIMARY RESEARCH
1.5. INFORMATION/DATA ANALYSIS
1.5.1. INFORMATION ANALYSIS
1.6. MARKET FORMULATION & VISUALIZATION
1.7. DATA VALIDATION & PUBLISHING
1.8. MODEL DETAILS
1.8.1. COMMODITY FLOW ANALYSIS
1.8.1.1. HYBRID MARKET ESTIMATION MODEL
1.8.1.2. GLOBAL MARKET: CAGR CALCULATION
1.9. LIST OF SECONDARY SOURCES
CHAPTER 2. EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT
2.2. SEGMENT SNAPSHOT BY ANIMAL TYPE & DISTRIBUTION CHANNEL
2.3. SEGMENT SNAPSHOT BY INDICATION
2.4. COMPETITIVE LANDSCAPE SNAPSHOT
CHAPTER 3. CBD PET MARKET VARIABLES, TRENDS, & SCOPE
3.1. MARKET LINEAGE OUTLOOK
3.1.1. PARENT MARKET ANALYSIS
3.1.2. ANCILLARY MARKET ANALYSIS
3.2. CBD PET MARKET DYNAMICS
3.2.1. MARKET DRIVER IMPACT ANALYSIS
3.2.1.1. INCREASING PET EXPENDITURE & PET HUMANIZATION
3.2.1.2. RISING AWARENESS & SALES OF CBD PRODUCTS
3.2.1.3. RISING R&D INITIATIVES
3.2.2. MARKET RESTRAINT IMPACT ANALYSIS
3.2.2.1. COMPLEX REGULATORY GUIDELINES
3.2.2.2. IMPROPER USAGE OF CBD PRODUCTS
3.3. MARKET OPPORTUNITY ANALYSIS
3.4. CBD PET MARKET: PORTER’S 5 FORCES ANALYSIS
3.4.1. BARGAINING POWER OF BUYERS: MODERATE
3.4.2. BARGAINING POWER OF SUPPLIERS: MODERATE
3.4.3. THREAT OF NEW ENTRANTS: HIGH
3.4.4. THREAT OF SUBSTITUTES: MODERATE TO HIGH
3.4.5. COMPETITIVE RIVALRY: MODERATE TO HIGH
3.5. CBD PET MARKET: PESTEL ANALYSIS
3.5.1. POLITICAL & LEGAL
3.5.2. ECONOMIC & SOCIAL
3.5.3. TECHNOLOGICAL
3.5.4. ENVIRONMENTAL
3.6. REGULATORY FRAMEWORK
3.6.1. NORTH AMERICA
3.6.1.1. U.S.
3.6.1.2. CANADA
3.6.2. EUROPE
3.6.2.1. GERMANY
3.6.2.2. UK
3.6.2.3. FRANCE
3.6.2.4. SPAIN
3.6.3. ASIA PACIFIC
3.6.3.1. CHINA
3.6.3.2. INDIA
3.6.3.3. AUSTRALIA
3.6.4. LATIN AMERICA
3.6.4.1. BRAZIL
3.6.4.2. MEXICO
3.6.4.3. ARGENTINA
3.6.5. MEA
3.6.5.1. SOUTH AFRICA
3.6.5.2. SAUDI ARABIA
3.7. PRODUCT PIPELINE ANALYSIS
3.8. PRICE-BASED ANALYSIS
3.9. COVID-19 IMPACT ANALYSIS
3.10. ESTIMATED PET POPULATION, BY KEY SPECIES & KEY COUNTRIES, 2024 TO 2025
CHAPTER 4. ANIMAL TYPE ESTIMATES & TREND ANALYSIS, 2025 - 2033
4.1. CBD PET MARKET BY ANIMAL TYPE: KEY TAKEAWAYS
4.2. ANIMAL TYPE MOVEMENT ANALYSIS & MARKET SHARE, 2023 & 2030
4.3. CBD PET MARKET ESTIMATES & FORECAST, BY ANIMAL TYPE (USD MILLION)
4.3.1. DOGS
4.3.1.1. DOGS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.1.2. FOODS/TREATS
4.3.1.2.1. FOODS/TREATS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.1.3. VITAMINS & SUPPLEMENTS
4.3.1.3.1. VITAMINS & SUPPLEMENTS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.2. CATS
4.3.2.1. CATS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.2.2. FOODS/TREATS
4.3.2.2.1. FOODS/TREATS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.2.3. VITAMINS & SUPPLEMENTS
4.3.2.3.1. VITAMINS & SUPPLEMENTS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
4.3.3. OTHERS
4.3.3.1. OTHER MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 5. INDICATION ESTIMATES & TREND ANALYSIS, 2025 - 2033
5.1. CBD PET MARKET BY INDICATION: KEY TAKEAWAYS
5.2. INDICATION MOVEMENT ANALYSIS & MARKET SHARE, 2023 & 2030
5.3. CBD PET MARKET ESTIMATES & FORECAST, BY INDICATION (USD MILLION)
5.3.1. JOINT PAIN
5.3.1.1. JOINT PAIN MARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.3.2. ANXIETY/STRESS
5.3.2.1. ANXIETY/STRESS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.3.3. EPILEPSY
5.3.3.1. EPILEPSY MARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.3.4. GENERAL HEALTH/WELLNESS
5.3.4.1. GENERAL HEALTH/WELLNESS MARKET ESTIMATES AND FORECASTS, 2025 - 2033
5.3.5. OTHERS
5.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 6. DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS, 2025 - 2033
6.1. CBD PET MARKET BY DISTRIBUTION CHANNEL: KEY TAKEAWAYS
6.2. DISTRIBUTION CHANNEL MOVEMENT ANALYSIS & MARKET SHARE, 2023 & 2030
6.3. CBD PET MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL (USD MILLION)
6.3.1. PET SPECIALTY STORES
6.3.1.1. PET SPECIALTY STORES MARKET ESTIMATES AND FORECASTS, 2025 - 2033
6.3.2. E-COMMERCE
6.3.2.1. E-COMMERCE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
6.3.3. CBD STORE
6.3.3.1. CBD STORE MARKET ESTIMATES AND FORECASTS, 2025 - 2033
6.3.4. OTHERS
6.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 7. CHAPTER 07 REGIONAL ESTIMATES & TREND ANALYSIS, 2025 - 2033
7.1. REGIONAL OUTLOOK
7.2. REGIONAL MARKET SHARE ANALYSIS, 2023 & 2030
7.3. REGIONAL MARKETPLACE, KEY TAKEAWAYS
7.4. REGIONAL MARKETPLACE, KEY TAKEAWAYS
7.5. NORTH AMERICA
7.5.1. NORTH AMERICA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.2. U.S.
7.5.2.1. KEY COUNTRY DYNAMICS
7.5.2.2. U.S. CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.5.3. CANADA
7.5.3.1. KEY COUNTRY DYNAMICS
7.5.3.2. CANADA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6. EUROPE
7.6.1. EUROPE CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.2. GERMANY
7.6.2.1. KEY COUNTRY DYNAMICS
7.6.2.2. GERMANY CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.3. UK
7.6.3.1. KEY COUNTRY DYNAMICS
7.6.3.2. UK CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.4. FRANCE
7.6.4.1. KEY COUNTRY DYNAMICS
7.6.4.2. FRANCE CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.5. SPAIN
7.6.5.1. KEY COUNTRY DYNAMICS
7.6.5.2. SPAIN CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.6.6. ITALY
7.6.6.1. KEY COUNTRY DYNAMICS
7.6.6.2. ITALY CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7. ASIA PACIFIC
7.7.1. ASIA PACIFIC CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.2. JAPAN
7.7.2.1. KEY COUNTRY DYNAMICS
7.7.2.2. JAPAN CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.3. CHINA
7.7.3.1. KEY COUNTRY DYNAMICS
7.7.3.2. CHINA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.4. INDIA
7.7.4.1. KEY COUNTRY DYNAMICS
7.7.4.2. INDIA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.5. AUSTRALIA
7.7.5.1. KEY COUNTRY DYNAMICS
7.7.5.2. AUSTRALIA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.7.6. SOUTH KOREA
7.7.6.1. KEY COUNTRY DYNAMICS
7.7.6.2. SOUTH KOREA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.8. LATIN AMERICA
7.8.1. LATIN AMERICA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.8.2. BRAZIL
7.8.2.1. KEY COUNTRY DYNAMICS
7.8.2.2. BRAZIL CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.8.3. MEXICO
7.8.3.1. KEY COUNTRY DYNAMICS
7.8.3.2. MEXICO CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.8.4. ARGENTINA
7.8.4.1. KEY COUNTRY DYNAMICS
7.8.4.2. ARGENTINA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.9. MIDDLE EAST AND AFRICA
7.9.1. MEA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.9.2. SOUTH AFRICA
7.9.2.1. KEY COUNTRY DYNAMICS
7.9.2.2. SOUTH AFRICA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
7.9.3. SAUDI ARABIA
7.9.3.1. SAUDI ARABIA CBD PET MARKET ESTIMATES AND FORECASTS, 2025 - 2033
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. MARKET PARTICIPANT CATEGORIZATION
8.2. COMPANY MARKET POSITION ANALYSIS/ HEAT MAP ANALYSIS
8.3. ESTIMATED COMPANY MARKET SHARE ANALYSIS, 2023
8.4. STRATEGY MAPPING
8.4.1. MERGERS & ACQUISITIONS
8.4.2. PARTNERSHIPS & COLLABORATIONS
8.4.3. OTHERS
8.5. COMPANY PROFILES
8.5.1. HONEST PAWS LLC
8.5.1.1. PARTICIPANT’S OVERVIEW
8.5.1.2. FINANCIAL PERFORMANCE
8.5.1.3. PRODUCT BENCHMARKING
8.5.1.4. STRATEGIC INITIATIVES
8.5.2. CANNA-PET LLC.
8.5.2.1. PARTICIPANT’S OVERVIEW
8.5.2.2. FINANCIAL PERFORMANCE
8.5.2.3. PRODUCT BENCHMARKING
8.5.2.4. STRATEGIC INITIATIVES
8.5.3. LABORATOIRE FRANCODEX.
8.5.3.1. PARTICIPANT’S OVERVIEW
8.5.3.2. FINANCIAL PERFORMANCE
8.5.3.3. PRODUCT BENCHMARKING
8.5.3.4. STRATEGIC INITIATIVES
8.5.4. PET RELEAF.
8.5.4.1. PARTICIPANT’S OVERVIEW
8.5.4.2. FINANCIAL PERFORMANCE
8.5.4.3. PRODUCT BENCHMARKING
8.5.4.4. STRATEGIC INITIATIVES
8.5.5. HOLISTAPET.
8.5.5.1. PARTICIPANT’S OVERVIEW
8.5.5.2. FINANCIAL PERFORMANCE
8.5.5.3. PRODUCT BENCHMARKING
8.5.5.4. STRATEGIC INITIATIVES
8.5.6. JOY ORGANICS
8.5.6.1. PARTICIPANT’S OVERVIEW
8.5.6.2. FINANCIAL PERFORMANCE
8.5.6.3. PRODUCT BENCHMARKING
8.5.6.4. STRATEGIC INITIATIVES
8.5.7. WET NOSES NATURAL DOG TREAT CO.
8.5.7.1. PARTICIPANT’S OVERVIEW
8.5.7.2. FINANCIAL PERFORMANCE
8.5.7.3. PRODUCT BENCHMARKING
8.5.7.4. STRATEGIC INITIATIVES
8.5.8. CBD LIVING.
8.5.8.1. PARTICIPANT’S OVERVIEW
8.5.8.2. FINANCIAL PERFORMANCE
8.5.8.3. PRODUCT BENCHMARKING
8.5.8.4. STRATEGIC INITIATIVES
8.5.9. PETSTOCK.
8.5.9.1. PARTICIPANT’S OVERVIEW
8.5.9.2. FINANCIAL PERFORMANCE
8.5.9.3. PRODUCT BENCHMARKING
8.5.9.4. STRATEGIC INITIATIVES
8.5.10. GARMON CORP.
8.5.10.1. PARTICIPANT’S OVERVIEW
8.5.10.2. FINANCIAL PERFORMANCE
8.5.10.3. PRODUCT BENCHMARKING
8.5.10.4. STRATEGIC INITIATIVES
8.5.11. CHARLOTTE’S WEB, INC.
8.5.11.1. PARTICIPANT’S OVERVIEW
8.5.11.2. FINANCIAL PERFORMANCE
8.5.11.3. PRODUCT BENCHMARKING
8.5.11.4. STRATEGIC INITIATIVES
8.5.12. GREEN ROADS.
8.5.12.1. PARTICIPANT’S OVERVIEW
8.5.12.2. FINANCIAL PERFORMANCE
8.5.12.3. PRODUCT BENCHMARKING
8.5.12.4. STRATEGIC INITIATIVES
8.5.13. HEMPMY PET.
8.5.13.1. PARTICIPANT’S OVERVIEW
8.5.13.2. FINANCIAL PERFORMANCE
8.5.13.3. PRODUCT BENCHMARKING
8.5.13.4. STRATEGIC INITIATIVES
8.5.14. FOMO BONES
8.5.14.1. PARTICIPANT’S OVERVIEW
8.5.14.2. FINANCIAL PERFORMANCE
8.5.14.3. PRODUCT BENCHMARKING
8.5.14.4. STRATEGIC INITIATIVES
CHAPTER 9. KEY TAKEAWAYS
著作権 ©2022 無断複写・転載を禁じます
